Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.8B | 3.9B | 3.5B | 3.6B |
Cost of revenue | 2.5B | 2.3B | 2.3B | 2.3B |
Gross profit | 1.3B | 1.6B | 1.2B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -88M |
Other operating expenses | — | — | 623M | 606M |
Operating income | 1.3B | 1.6B | 1.2B | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 216M | 203M | 192M | 200M |
Other income expense | 100M | 88M | 88M | 128M |
Pretax income | 1.2B | 1.4B | 1.1B | 1.2B |
Tax provision | 292M | 246M | 262M | 292M |
Net income | 909M | 1.2B | 837M | 903M |
Basic EPS | 1.0 | 1.3 | 0.9 | 1.0 |
Diluted EPS | 1.0 | 1.3 | 0.9 | 1.0 |
Basic average shares | 933.2M | 933.4M | 933.2M | 932.8M |
Diluted average shares | 934.3M | 934.8M | 935.3M | 934.6M |
EBITDA | 1.9B | 2.1B | 1.8B | 1.9B |
Net income from continuing op. | 909M | 1.2B | 837M | 903M |
Minority interests | 1M | 2M | 0 | 2M |
Preferred stock dividends | — | — | — | — |